Euroapi (LTS:0EAP) Beta: N/A (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0EAP Euroapi SA LTS:0EAP
35 GF Score
Price €1.28
GF Value €2.87
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Euroapi Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-15), Euroapi's Beta is Not available.

Euroapi  (LTS:0EAP) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Euroapi Beta Related Terms

Euroapi Beta Historical Data

* Premium members only.

The historical data trend for Euroapi's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euroapi Beta Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LTS:0EAP
35GF Score
Euroapi SA LTS:0EAP
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Euroapi Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Euroapi (LTS:0EAP) Overvalued in 2026?

Based on GuruFocus' analysis, Euroapi stock appears to be undervalued. The current stock price of €1.28 is trading 55.6% below its estimated GF Value™ of €2.87. GuruFocus considers Euroapi to be Possible Value Trap.

Key valuation signals for LTS:0EAP:

  • Beta: N/A
  • GF Value™: €2.87 vs. price of €1.28 (55.6% below fair value)
  • GF Score™: 35/100 with 6 warning signs

No single metric tells the full story. See the LTS:0EAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Euroapi Business Description

Address 32 rue Alexandre Duma, Paris, FRA, 75011
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates, analgesics, and others. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.
35GF Score

Get the complete analysis for LTS:0EAP

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.28
Price
€2.87
GF Value